Senate Republicans Reject Sanders' Amendment to Lower Drug Prices

In a recent Senate vote, Republicans rejected an amendment proposed by Senator Bernie Sanders (I-Vt.) aimed at significantly reducing prescription drug prices in the United States. The amendment sought to ensure that Americans would not pay more for medications than citizens in Canada and other wealthy nations. The vote, which took place in the early hours of Thursday morning, resulted in a tie of 49-49, with Sanders requiring 60 votes to attach his proposal to the GOP's budget reconciliation package, primarily intended to fund the Department of Homeland Security and its agencies, including Immigration and Customs Enforcement (ICE) and Customs and Border Protection (CBP).

Common Dreams

The proposed amendment was straightforward: it would prevent pharmaceutical companies from charging higher prices for prescription drugs in the U.S. than they do in Canada, the United Kingdom, Germany, France, and Japan. Sanders emphasized that Americans currently pay, on average, at least twice as much for prescription drugs as individuals in these countries. He noted that one in four Americans cannot afford their prescribed medications, leading to dire health consequences.

TruthOut

During the Senate debate, Sanders highlighted the inconsistency between President Donald Trump's previous support for a "most favored nation" drug pricing policy and the Republican opposition to the amendment. Trump had signed an executive order directing federal health officials to align U.S. drug prices with those in comparable nations, but experts argue that without congressional action, this order lacks enforceability. Sanders stated, "If Trump is serious about making real change rather than just issuing a press release, he will support legislation I will soon be introducing."

Common DreamsTruthOutThe Hill

The Prescription Drug Price Relief Act, introduced by Sanders and several Democratic colleagues, aims to review brand-name drugs annually for excessive pricing. A price is deemed excessive if it exceeds the median price in the aforementioned countries or is higher than reasonable based on factors such as development costs and patient population size.

Common Dreams

The overwhelming majority of Senate Republicans opposed the amendment, putting them on record against a policy that had previously garnered support from Trump. Only two Republicans, Senators Josh Hawley (Mo.) and Dan Sullivan (Alaska), voted in favor of the amendment alongside all present Democrats. Critics argue that the rejection of the amendment reflects a broader unwillingness among Republicans to address the escalating costs of prescription drugs, which continue to rise despite previous executive actions.

The Hill

While the amendment aimed to address the high cost of prescription drugs, the failure to pass it raises questions about the future of drug pricing reform in the U.S. The lack of bipartisan support for such measures indicates a significant gap in legislative action, despite public demand for lower drug prices.

TruthOut

• “The American people pay by far the highest prices in the world for prescription drugs, and the result is 1 out of 4 Americans cannot afford the prescriptions that their doctors write, and thousands die every year as a result,” — Bernie Sanders, U.S. Senator

The Hill

• “This amendment is very simple. It would prevent pharmaceutical companies from charging more for prescription drugs in the United States than they do in Canada, the U.K., Germany, France and Japan.” — Bernie Sanders, U.S. Senator

The Hill

The rejection of Sanders' amendment underscores the ongoing debate over drug pricing in the U.S. and the challenges faced in achieving meaningful reform.

The Hill